CTRI/2013/05/003681招募中未知
A GLOBAL, MULTICENTER, PROSPECTIVE, REAL WORLD OBSERVATIONAL STUDY FOR LEFT MAIN DISEASE TREATMENT - IRIS MAI
SeungJung Park0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Significant unprotected left main stenosis ( >50% by visual estimation)
- •â?¦The LMCA is considered unprotected if there are no patent coronary artery bypass grafts to the left anterior descending artery or the left circumflex artery.
- •No limitation of clinical or lesion characteristics
- •Age >18 years
- •The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.
排除标准
- •Protected left main stenosis
研究者
相似试验
招募中
Unknown
An observational registry study of Eternia Coronary Stent Systemin coronary artery diseased patients of Indian populatioCTRI/2023/10/058735Innvolution Healthcare Private Limited
Unknown
3 期
An Investigator-initiated and conducted, collaborative,phase III, multi-centre,open label, randomised,controlled trial of continuous positive airway pressure for the treatment of obstructive sleep apnea to prevent cardiovascular disease.CTRI/2009/091/000410Adelaide Institute for Sleep Health5,000
进行中（未招募）
不适用
A PROSPECTIVE, INTERNATIONAL, MULTI-CENTRIC, OPEN-LABEL STUDY TO ASSESS THE EFFICACY OF AN EXTENDED INJECTION INTERVAL SCHEDULE OF LANREOTIDE AUTOGEL 120 MG IN ACROMEGALIC SUBJECTS WHO ARE BIOCHEMICALLY CONTROLLED ON THE LONG TERM TREATMENT WITH OCTREOTIDE LAR 10 OR 20 MGAcromegalyEUCTR2007-005838-37-NLBeaufour Ipsen Pharma150
进行中（未招募）
不适用
A PROSPECTIVE, INTERNATIONAL, MULTI-CENTRIC, OPEN-LABEL STUDY TO ASSESS THE EFFICACY OF AN EXTENDED INJECTION INTERVAL SCHEDULE OF LANREOTIDE AUTOGEL 120 MG IN ACROMEGALIC SUBJECTS WHO ARE BIOCHEMICALLY CONTROLLED ON THE LONG TERM TREATMENT WITH OCTREOTIDE LAR 10 OR 20 MGMedDRA version: 9.1Level: LLTClassification code 10000599Term: AcromegalyAcromegalyEUCTR2007-005838-37-LVIpsen Pharma150
进行中（未招募）
1 期
A PROSPECTIVE, INTERNATIONAL, MULTI-CENTRIC, OPEN-LABEL STUDY TO ASSESS THE EFFICACY OF AN EXTENDED INJECTION INTERVAL SCHEDULE OF LANREOTIDE AUTOGEL 120 MG IN ACROMEGALIC SUBJECTS WHO ARE BIOCHEMICALLY CONTROLLED ON THE LONG TERM TREATMENT WITH OCTREOTIDE LAR 10 OR 20 MG - LEADAcromegalyEUCTR2007-005838-37-FRBeaufour Ipsen Pharma124